Connect with us

News

Charlie Sheen Launches Line of Cannabis Vape Products

Avatar

Published

on

Actor Charlie Sheen announced his new line of cannabis-infused vape products aptly named Sheenius. In a video interview with DailyMailTV, the 53-year-old walked through his business plan with a theatrical twist. Sheen has been developing the idea for Sheenius for at least a year.

As recently as December 2018, Sheen announced that he’s hit the one-year milestone in his path to sobriety from drugs and alcohol. Sheen admitted that he doesn’t use the products himself, as he’s still on his path to sobriety. But recently, Sheen and his associates noticed rogue strains like Charlie Sheen or Charlie Sheen OG popping up everywhere. “They said, you know, we see your name so ingrained in the marijuana industry. And it’s all bootlegged essentially, I’ve never made a nickel off of it. That didn’t seem fair,” he told DailyMailTV.

The vape pen flavors will include, shall we say, quirky names such as Milli’s Vanili, MaliBlu Dream, The Legend, Grandma’s Perfume and Clown Mace. In the video, Sheen wears a lab coat as he explores pH Solutions in Monrovia, California with Laboratory Director Raquel Keledjian.

In the video, at one point, a man dressed as a clown appears to promote the Clown Mace flavor vape products. “Clown Mace is pretty good, because what clown shouldn’t be maced?” he said. “One of our favorites is Grandma’s Perfume. Sometimes it’s more about how words sound together, and then you start creating images, visuals behind the feelings those words create. We just wanted it to feel inviting and to generate curiosity—like what is a vape strain called ‘Mama Said No?’”

Sheen’s extensive career in Hollywood is overshadowed by bouts of controversy—including allegations of sexual assault and his 2015 announcement of his diagnosis of HIV. Despite a growing body of evidence to support the idea that cannabinoids may slow the progression of HIV, most particularly tetrahydrocannabinol, Sheen doesn’t turn to cannabis for medical reasons.

The products become available April 2 in about 20 dispensaries and prices range between $60 and $70.

 

 

News

Strain of the Week: Midnite

Avatar

Published

on

Whoever first said that “nothing good happens after midnight” clearly was not enjoying life. Maybe it was said to perpetuate safety, specifically toward rambunctious youth who went gallivanting around in the forest at night. Or maybe it was more geared toward superstitious beliefs about witches or paranormal entities who roam around when the sun goes down. Either way, whoever said it definitely hadn’t seen a Gremlins movie, which contrary to the plot which warns against feeding a Gremlin at night, is one of the weirdest and best 1980s movies ever (change our mind). Ultimately though, cannabis after midnight can be a treat, especially when it’s a strain like Midnite.

Midnite is a cross between Bubba Kush and Chem #4. Bubba Kush is well-known for its earthiness, deep pine aroma and ability to induce sleep (not to mention that, as reviewers put it, it’s so widely loved that consuming it is often like “greeting an old friend at the airport”). Chem #4, which is also short for Chemdog/Chemdawg, is a zesty hybrid, complete with scents and flavors of lemon, that delivers full body effects of relaxation and euphoria. Between these two powerhouse strains create a unique strain child that’s full of potential.

Described as light green and denser than a dogwood tree, Midnite strain samples were absolutely covered in frosty trichomes—so much that it almost seemed like it was covered in freshly fallen snow, or even might glow when placed in a dark place. Surprisingly, the bud didn’t have much of a scent until it was ground up, revealing a potent chemmy aroma that made our seasoned reviewers salivate. Upon inhalation, the flower was robust but not harsh, leading to full body relaxation that didn’t feel lethargic. It won’t stop anyone from getting a full night’s sleep when ready to crash, however, and the rest of its qualities were deep and relaxing.

Continue Reading

News

Virginia to Focus on Legal Cannabis in 2021 Legislative Session

Avatar

Published

on

Some legislators in Virginia are planning on pushing for support to consider recreational cannabis this year.

The 2021 legislative session in Virginia, which began on January 13, will be conducted remotely as the pandemic continues to be a major concern. The state’s House of Delegates will be meeting entirely remotely, and the Vermont Senate will meet at a conference center instead of at the state capitol building.

To start off this year’s legislative session, there are multiple topics on the table for discussion, including COVID-19 relief and the death penalty repeal. But perhaps the most contentious issue of all is the discussion of recreational cannabis legalization.

During this legislative push, Governor Ralph Northam is once again making it known that he would like to see recreational cannabis legalized. If Virginia legislators make a move, they will be the first Southern state to fully legalize cannabis. Currently, the state only allows medical cannabis, which went into effect on July 1, 2020.

Northam, who has been speaking out in favor of recreational legalization since November 2020, would like to see a legal approach that makes sure youth safety is high priority and also prioritizes the struggle of marginalized people disproportionately affected by the War on Drugs.

The success of this push for legalization will hinge on whether or not there are enough votes in the legislature in favor of legal cannabis for it to pass. However, even Republicans are coming around to cannabis issues in many states, and Virginia has successfully decriminalized cannabis and legalized a medical program.

Despite the fact that the state has already laid the groundwork for full, recreational legalization, it remains to be seen whether Virginia will follow through and successfully legalize cannabis this year.

Continue Reading

News

WSU Study Finds Cannabis May Diminish Stress Response

Avatar

Published

on

A new study from Washington State University (WSU) has found that cannabis may diminish a user’s physiological response to stress.

Researchers found female rats that self-administered daily puffs of cannabis vapor for a month had lower blood levels of a hormone that causes stress when presented with a stressful situation than they did at the beginning of the experiment and compared to a control group. The rats were trained to trigger an infrared sensor that would activate a puff of cannabis vapor anytime they felt the urge. Previous studies have shown cannabis could have an effect on stress response.

After 30 days, only female rats that had access to the cannabis had a significantly muted response to stress. The rats that were given access to cannabis also tended to respond more for the substance and had higher concentrations in their blood after the experiment. Male rats did not experience the same results, but they also self-administered a lot less.  

“We don’t know if this is a good thing or a bad thing and there’s reason to argue for either of them at this point—a blunted stress response might actually predispose some people to certain mental health conditions is our concern,” said co-author of the study and WSU assistant professor of psychology, Carrie Cuttler. “So yeah, it sounds great on the surface that maybe they’re less prone to stress…but the stress response is an important system that exists for a reason—any alterations in that or perturbations in that system may or may not be a good thing.”

WSU assistant professor and another co-author of the study, Ryan McClain, mentioned there are ethical and legal concerns with testing stress responses on humans, as well as administering cannabis to some of the human participants, so these kinds of studies are limited to animal models.

Continue Reading

Newsletter

Trending